Prognostic impact on FOXP3 expression in triple-negative breast cancer (TNBC)

被引：0
|
作者：
Lee, S.
Park, Y. H.
Cho, E. Y.
Ham, Y. H.
Seo, J. J.
Ahn, J. S.
Im, Y.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.1089
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1089
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Race-specific gene expression patterns in triple-negative breast cancer (TNBC) cases
    Martini, Rachel
    White, Jason
    Verma, Akanksha
    Elemento, Olivier
    Newman, Lisa
    Upender, Manne
    Yates, Clayton
    Davis, Melissa
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [42] Meeting the educational needs of women with triple-negative breast cancer (TNBC).
    Swiger, Kathleen Dickerson
    Sendecki, Jocelyn A.
    Guglielmino, Janine E.
    Rugo, Hope S.
    Domchek, Susan M.
    Anders, Carey K.
    Stricker, Carrie Tompkins
    Nelson, Hillary C. M.
    Hanson, Arin Ahlum
    Dinerman, Hayley
    Henry, Catherine Creme
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
    Lee, Jieun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [44] Discovery of a small molecule inhibitor for triple-negative breast cancer (TNBC)
    Saran, Uttara
    Chandrasekaran, Balaji
    Tyagi, Ashish
    Singh, Amandeep
    Ankem, Murali K.
    Sharma, Arun K.
    Damodaran, Chendil
    CANCER RESEARCH, 2022, 82 (12)
  • [45] Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review
    Tajbakhsh, Amir
    Rivandi, Mandi
    Abedini, Soheila
    Pasdar, Alireza
    Sahebkar, Amirhossein
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 140 : 17 - 27
  • [46] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [47] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho
    Myung Hee Chang
    Yoon La Choi
    Jeong Eon Lee
    Seok Jin Nam
    Jung-Hyun Yang
    Yeon Hee Park
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 753 - 761
  • [48] Folate receptor alpha (FOLR1) expression in triple-negative breast cancer (TNBC)
    Cui, X.
    McIntire, P. J.
    Ginter, P. S.
    Irshaid, L.
    Chen, Z.
    Shin, S. J.
    CANCER RESEARCH, 2017, 77
  • [49] Inducing cell state transitions in triple-negative breast cancer (TNBC).
    Loo, Ser Yue
    Toh, Liping
    Pathak, Elina
    Tan, Wilson
    Ma, Siming
    Yuan, Ju
    Periyasamy, Giridharan
    Torta, Federico
    Chan, Jack
    Tan, Tira
    Sim, Yi Rong
    Tan, Veronique
    Tan, Benita
    Madhukumar, Preetha
    Yong, Wei Sean
    Ong, Kong Wee
    Wong, Chow Yin
    Wenk, Markus R.
    Foo, Roger
    Yap, Yoon-Sim
    Lim, Elaine
    Tam, Wai Leong
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 73 - 73
  • [50] BRCA1 MUTATION AND ITS PROGNOSTIC ROLE IN THE TRIPLE-NEGATIVE BREAST CANCER (TNBC) SUBTYPE
    Maksimenko, J. J.
    Irmejs, A.
    Trofimovics, G.
    Miklasevics, E.
    BREAST, 2013, 22 : S32 - S33
12345